Firms to develop freeze-dried human plasma

Entegrion and Kedrion Melville agreed to collaborate in the development and commercialization of the former's freeze-dried human plasma Resusix, a shelf-stable alternative to fresh-frozen plasma. The partners plan to initiate clinical studies this year. Kedrion will invest in Entegrion under the agreement.

View Full Article in:

American City Business Journals · WRALTechWire.com (Raleigh, N.C.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC